These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Behavior of platelets and leukocytes on the luminal surface of small caliber polyurethane grafts. Matsumoto M; Ban T; Okamoto Y J Cardiovasc Surg (Torino); 1989; 30(4):609-13. PubMed ID: 2550468 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of aspirin for coronary artery disease. Fuster V; Cohen M; Chesebro JH Am J Cardiol; 1988 Mar; 61(8):637-40. PubMed ID: 3278582 [No Abstract] [Full Text] [Related]
7. [Prevention of occlusion following peripheral bypass surgery using oral anticoagulants or acetylsalicylic acid: a randomized comparison within the Dutch BOA study]. Tangelder MJ; Eikelboom BC; Lawson JA; Algra A Ned Tijdschr Geneeskd; 1995 Jul; 139(29):1504-6. PubMed ID: 7630459 [No Abstract] [Full Text] [Related]
8. [Behavior of platelets and leukocytes on the luminal surface of small caliber prosthetic grafts]. Matsumoto M Nihon Geka Hokan; 1988 Sep; 57(5):351-9. PubMed ID: 2855195 [No Abstract] [Full Text] [Related]
9. Dipyridamole plus aspirin and hemodialysis graft patency. Hentschel DM N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176 [No Abstract] [Full Text] [Related]
10. [Causes of thrombosis of autovenous transplants and methods for its prevention]. Klimov VN; Lur'e FE Klin Khir (1962); 1986; (7):29-31. PubMed ID: 3761881 [No Abstract] [Full Text] [Related]
11. A clinical commentary on the article "an early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia". Shenoy S J Cardiovasc Transl Res; 2011 Oct; 4(5):683-4. PubMed ID: 21842342 [No Abstract] [Full Text] [Related]
12. Optimal duration of antiplatelet therapy after implantation of a small-diameter polytetrafluoroethylene arterial prosthesis. Nordestgaard AG; Moller LP; Marcus CS; Wilson SE Curr Surg; 1987; 44(6):490-3. PubMed ID: 3428002 [No Abstract] [Full Text] [Related]
13. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design. Scharn DM; Daamen WF; van Kuppevelt TH; van der Vliet JA Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):66-72. PubMed ID: 22001149 [TBL] [Abstract][Full Text] [Related]
14. Occlusion after coronary revascularization. Pepine CJ J Am Coll Cardiol; 1990 May; 15(6):1259-60. PubMed ID: 2329229 [No Abstract] [Full Text] [Related]
15. [New study results in cardiology]. Stiefelhagen P Internist (Berl); 2006 Nov; 47(11):1186, 1188-90. PubMed ID: 17033779 [No Abstract] [Full Text] [Related]
16. Dipyridamole plus aspirin and hemodialysis graft patency. Weale AR; Cooper DG N Engl J Med; 2009 Aug; 361(7):720; author reply 721. PubMed ID: 19675337 [No Abstract] [Full Text] [Related]
17. Improvement of aortocoronary bypass patency by antiplatelet drug administration. Preliminary communication. Pirk J; Vojácek J; Kovác J Cor Vasa; 1986; 28(3):177-80. PubMed ID: 3527555 [TBL] [Abstract][Full Text] [Related]
18. Who might benefit from early aspirin after coronary artery surgery? Gukop P; Gutman N; Bilkhu R; Karapanagiotidis GT Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):505-11. PubMed ID: 24871533 [TBL] [Abstract][Full Text] [Related]
19. Platelet function and pharmacologic inhibition. Chaer RA; Graham JA; Mureebe L Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and prevention of aortocoronary bypass graft occlusion. Chesebro JH; Fuster V Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]